Rubinstein Julieinsider trades
In SEC Form 4 filings, Rubinstein Julie is listed as President and COO of Adaptive Biotechnologies Corp (ADPT). In the last 90 days, Rubinstein Julie sold $4.66M of Adaptive Biotechnologies Corp (ADPT) on the open market and bought none. All 25 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | President and COO | 55 | Oct 21 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-05
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | Oct 21 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 21 | Oct 21 | S | 5,999 | $25.25 | Sale −$151,475 | 383,684 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 21 | Oct 21 | S | 5,882 | $25.57 | Sale −$150,403 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 21 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 201,562 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 20 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 20 | Oct 21 | S | 11,781 | $24.53 | Sale −$288,988 | 377,902 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 20 | Oct 21 | S | 100 | $24.85 | Sale −$2,485 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 20 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 213,443 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 19 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 19 | Oct 21 | S | 11,881 | $24.05 | Sale −$285,738 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 19 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 225,324 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 16 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 16 | Oct 16 | S | 11,581 | $24.21 | Sale −$280,376 | 378,102 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 16 | Oct 16 | S | 300 | $25.45 | Sale −$7,635 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 16 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 237,205 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 15 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 15 | Oct 16 | S | 11,881 | $25.61 | Sale −$304,272 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 15 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 249,086 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 14 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 14 | Oct 16 | S | 6,781 | $25.57 | Sale −$173,390 | 382,902 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 14 | Oct 16 | S | 5,100 | $25.82 | Sale −$131,682 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 14 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 260,967 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 13 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 13 | Oct 13 | S | 11,881 | $25.50 | Sale −$302,966 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 13 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 272,848 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 12 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 12 | Oct 13 | S | 9,181 | $25.35 | Sale −$232,738 | 380,502 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 12 | Oct 13 | S | 2,700 | $26.07 | Sale −$70,389 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 12 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 284,729 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 9 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 9 | Oct 13 | S | 11,881 | $26.41 | Sale −$313,777 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 9 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 296,610 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 8 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 8 | Oct 8 | S | 11,881 | $25.66 | Sale −$304,866 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 8 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 308,491 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 7 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 7 | Oct 8 | S | 11,881 | $26.40 | Sale −$313,658 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 7 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 320,372 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | S | 9,381 | $27.36 | Sale −$256,664 | 380,302 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | S | 1,100 | $28.21 | Sale −$31,031 | 379,202 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | S | 901 | $29.71 | Sale −$26,769 | 378,301 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | S | 499 | $30.53 | Sale −$15,234 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 6 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 332,253 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 5 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 5 | Oct 5 | S | 6,699 | $28.82 | Sale −$193,065 | 382,984 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 5 | Oct 5 | S | 5,182 | $29.67 | Sale −$153,750 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 5 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 344,134 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 2 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 2 | Oct 5 | S | 11,881 | $28.13 | Sale −$334,213 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 2 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 356,015 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | S | 6,081 | $27.57 | Sale −$167,653 | 383,602 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | S | 5,800 | $28.56 | Sale −$165,648 | 377,802 | Yes | Form 4 |
| ADPTAdaptive Biotechnologies Corp | Oct 1 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 367,896 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.